Skip to main content
STAR COMBO PHARMA LIMITED logo

STAR COMBO PHARMA LIMITED — Investor Relations & Filings

Ticker · S66 ISIN · AU0000004798 ASX Manufacturing
Filings indexed 195 across all filing types
Latest filing 2026-02-24 Regulatory Filings
Country AU Australia
Listing ASX S66

About STAR COMBO PHARMA LIMITED

https://www.starcombo.com.au

Star Combo Pharma Limited specializes in the development, manufacturing, and distribution of vitamins, dietary supplements, and skincare products. The organization operates Therapeutic Goods Administration (TGA) licensed facilities, offering comprehensive Original Equipment Manufacturing (OEM) and Original Design Manufacturing (ODM) services. Its product portfolio encompasses a wide range of health and beauty solutions marketed under proprietary brands, including Costar, Living Healthy, Amax, and J&K. The company focuses on delivering premium health products to diverse markets, leveraging technical expertise in formulation and large-scale production. By maintaining rigorous quality control standards and providing end-to-end manufacturing solutions, the entity serves as a strategic partner for businesses seeking customized health and wellness products.

Recent filings

Filing Released Lang Actions
S66 Dec 25 Half Year Report and Financial Statements 22 pages 1.7MB
Regulatory Filings
2026-02-24 English
S66 CEO Presentation to 2025 AGM 16 pages 2.2MB
Regulatory Filings
2025-11-24 English
S66 - Resuts of Voting at 2025 AGM 2 pages 206.0KB
Regulatory Filings
2025-11-24 English
S66 2025 Annual Report 64 pages 9.8MB
Regulatory Filings
2025-10-23 English
S66 2025 AGM - NOM / EM / Proxy 8 pages 421.9KB
Regulatory Filings
2025-10-23 English
S66 2025 Corporate Governance Statement 11 pages 318.3KB
Regulatory Filings
2025-10-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.